455 related articles for article (PubMed ID: 26472630)
1. Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status.
Chen L; Sun J; Yang X
Cancer Lett; 2016 Jan; 370(1):78-84. PubMed ID: 26472630
[TBL] [Abstract][Full Text] [Related]
2. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
Eggert T; Greten TF
Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
[TBL] [Abstract][Full Text] [Related]
3. Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma.
Kan X; Jing Y; Wan QY; Pan JC; Han M; Yang Y; Zhu M; Wang Q; Liu KH
Eur Rev Med Pharmacol Sci; 2015; 19(2):247-55. PubMed ID: 25683938
[TBL] [Abstract][Full Text] [Related]
4. Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation.
Hyun D; Cho SK; Shin SW; Park KB; Park HS; Choo SW; Do YS; Choo IW; Lee MW; Rhim H; Lim HK
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):417-25. PubMed ID: 26246215
[TBL] [Abstract][Full Text] [Related]
5. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
Mahnken AH; Bruners P; Günther RW
Dig Dis; 2009; 27(2):148-56. PubMed ID: 19546553
[TBL] [Abstract][Full Text] [Related]
6. [Percutaneous ablation of hepatocellular carcinoma in older patients in clinical practice].
Romero Gutiérrez M; Ruano Díaz L; Muñoz López D; Artaza Varasa T; González de Frutos C; Sánchez Ruano JJ; de la Cruz Pérez G; Gómez Rodríguez R
Gastroenterol Hepatol; 2015 Feb; 38(2):54-61. PubMed ID: 25499846
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with sorafenib and radiofrequency ablation for BCLC Stage 0-B1 hepatocellular carcinoma: a multicenter retrospective cohort study.
Feng X; Xu R; Du X; Dou K; Qin X; Xu J; Jia W; Wang Z; Zhao H; Yang S; Guo C; Liu T; Ma K
Am J Gastroenterol; 2014 Dec; 109(12):1891-9. PubMed ID: 25403366
[TBL] [Abstract][Full Text] [Related]
8. Viable hepatocellular carcinoma around retained iodized oil after transarterial chemoembolization: radiofrequency ablation of viable tumor plus retained iodized oil versus viable tumor alone.
Kim JH; Kim PN; Won HJ; Shin YM
AJR Am J Roentgenol; 2014 Nov; 203(5):1127-31. PubMed ID: 25341154
[TBL] [Abstract][Full Text] [Related]
9. Combining radiofrequency ablation and ethanol injection may achieve comparable long-term outcomes in larger hepatocellular carcinoma (3.1-4 cm) and in high-risk locations.
Lin JW; Lin CC; Chen WT; Lin SM
Kaohsiung J Med Sci; 2014 Aug; 30(8):396-401. PubMed ID: 25002377
[TBL] [Abstract][Full Text] [Related]
10. Current status of the combination therapy of transarterial chemoembolization and local ablation for hepatocellular carcinoma.
Li W; Ni CF
Abdom Radiol (NY); 2019 Jun; 44(6):2268-2275. PubMed ID: 31016345
[TBL] [Abstract][Full Text] [Related]
11. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
[TBL] [Abstract][Full Text] [Related]
12. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation alone versus radiofrequency ablation combined with chemoembolization in unresectable hepatocellular carcinoma.
Siriapisith T; Siwasattayanon P; Tongdee T
J Med Assoc Thai; 2012 Mar; 95(3):430-6. PubMed ID: 22550844
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
Wang W; Shi J; Xie WF
Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.
Kim JW; Kim JH; Won HJ; Shin YM; Yoon HK; Sung KB; Kim PN
Eur J Radiol; 2012 Mar; 81(3):e189-93. PubMed ID: 21353417
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation and chemoembolization for hepatocellular carcinoma.
Georgiades CS; Hong K; Geschwind JF
Cancer J; 2008; 14(2):117-22. PubMed ID: 18391617
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib Combined with Radio-frequency Ablation Compared with Sorafenib Alone in Treatment of Hepatocellular Carcinoma Invading Portal Vein: A Western Randomized Controlled Trial.
Giorgio A; Merola MG; Montesarchio L; Merola F; Santoro B; Coppola C; Gatti P; Amendola F; DI Sarno A; Calvanese A; Matteucci P; Giorgio V
Anticancer Res; 2016 Nov; 36(11):6179-6183. PubMed ID: 27793949
[TBL] [Abstract][Full Text] [Related]
18. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial.
Cheng BQ; Jia CQ; Liu CT; Fan W; Wang QL; Zhang ZL; Yi CH
JAMA; 2008 Apr; 299(14):1669-77. PubMed ID: 18398079
[TBL] [Abstract][Full Text] [Related]
19. Effects of sorafenib combined with chemoembolization and radiofrequency ablation for large, unresectable hepatocellular carcinomas.
Liang HY; Lu LG; Hu BS; Li Y; Shao PJ
Chin Med J (Engl); 2013 Nov; 126(22):4270-6. PubMed ID: 24238511
[TBL] [Abstract][Full Text] [Related]
20. Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone.
Kim JH; Won HJ; Shin YM; Kim SH; Yoon HK; Sung KB; Kim PN
Ann Surg Oncol; 2011 Jun; 18(6):1624-9. PubMed ID: 21445671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]